modified phospholipid vesicles as drug delivery systems for the treatment of leishmaniasis
Published 3 years ago • 294 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
41:59
phospholipid-free small unilamellar vesicles (pfsuvs) for hepatocyte-targeted drug delivery
-
2:07
liposomal delivery systems in cancer therapy - creative biolabs
-
1:48
stars in global health: anny fortin
-
1:06
dyslipidemia screening
-
32:03
in vitro permeation as a development tool for transdermal and topical patches
-
7:37
the leishmaniasis east african platform (leap) - 2018
-
1:40
vulnerabilities in lipid synthesis pathways and resistance to imids and celmods in multiple myeloma
-
1:48
treatment of dyslipidemias: what is new? - ian graham
-
3:48
novel rgd-lipid conjugate-modified liposomes - video abstract: 24447
-
0:42
hydrophilicity of cerabone®
-
2:29
optimal prehospital crystalloid volume
-
5:19
leishmaniasis east african platform (leap) - dndi
-
1:09:38
upgrading the sequential therapy tool kit for b-cell malignancies
-
5:28
harshini ashar - treating implant-associated osteomyelitis with fus and liposomes (2020)
-
1:29
extracellular vesicles from modified vascular cells induce neurogenesis
-
1:30
altogen labs liposome encapsulation services
-
4:13
scs or prostacyclin in unrevascularizable critical limb ischemia -video abstract 57199
-
2:43
protein-entrapped liposomes and lipoparticles - video abstract: 25646
-
8:27
liposomal delivery systems in cancer therapy - creative biolabs